New diabetes clinical trial: Insulin Glargine U300 vs Insulin Degludec U100 in Impact on the Glycaemic and Cardiovascular Factors
Published on: December 31, 2020 at 10:30PM
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Degludec; Drug: Glargine U300
Sponsors: University of Split, School of Medicine; Pavle Vrebalov Cindro; Jonatan Vuković; Darko Modun; Božo Smajić; Gordan Kardum; Tina Tičinović Kurir; Doris Rušić; Ana Šešelja Perišin; Josipa Bukić
Completed
https://ift.tt/383uLyi
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Degludec; Drug: Glargine U300
Sponsors: University of Split, School of Medicine; Pavle Vrebalov Cindro; Jonatan Vuković; Darko Modun; Božo Smajić; Gordan Kardum; Tina Tičinović Kurir; Doris Rušić; Ana Šešelja Perišin; Josipa Bukić
Completed
https://ift.tt/383uLyi
Comments
Post a Comment